Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Objective: This study aimed to compare the early- and mid-term results of valve-sparing surgery and valve replacement surgery, which require different approaches to intraoperative/postoperative patient care, in patients with type A aortic dissection.

Methods: In this retrospective study, 112 consecutive patients (83 males, 29 females; mean age: 54.8±12.2 years) who underwent an operation for type A aortic dissection between February 2019 and September 2022 were examined. Patients were divided into two groups: those who underwent valve replacement surgery (modified Bentall procedure, SCI+AVR; n=26, 23.2%) and those who underwent valve-sparing surgery (isolated SCI, David II procedure, SCI+AV resuspension; n=86, 76.8%).

Results: It was observed that the cross-clamp and cardiopulmonary bypass times were longer and the need for postoperative mechanical support was higher in the valve replacement group (p<0.05). The early mortality rate was 30.8% (n=8) in the valve replacement group and 22.1% (n=19) in the valve-sparing group. The survival times were found to be 15.9 days in the valve replacement group and 123.5 days in the valve-sparing group. The mean postoperative control computed tomography time was 21.0±12.6 months. There was no postoperative sinus of Valsalva aneurysm in the valve-sparing group. Although the false lumen patency rate was not statistically significant, it was higher in the valve replacement group. After the operation, moderate to severe aortic regurgitation was not observed in any of the patients who underwent valve-sparing surgery with preoperative moderate to severe aortic regurgitation.

Conclusion: The results indicate that valve-sparing surgery was superior to valve replacement surgery for type A aortic dissection patients.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12045195PMC
http://dx.doi.org/10.5606/tgkdc.dergisi.2024.mob-02DOI Listing

Publication Analysis

Top Keywords

valve replacement
16
valve-sparing surgery
12
replacement surgery
12
type aortic
12
mid-term valve-sparing
8
surgery valve
8
aortic dissection
8
surgery
6
[mÖb-02] comparison
4
comparison early
4

Similar Publications

Clinical outcomes following TAVR for patients with low and very low gradient aortic stenosis.

Prog Cardiovasc Dis

September 2025

Department of Cardiovascular Medicine, Heart, Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address:

Objectives: This study explores the impact of lower baseline aortic valve (AV) mean gradients on the clinical outcomes of patients with low-gradient aortic stenosis (LG AS) post-transcatheter aortic valve replacement (TAVR). Additionally, the study aims to understand the predictors of a lower baseline AV mean gradient (MG).

Background: Reduced left ventricular ejection fraction (LVEF) and low-flow states are known to correlate with worse clinical outcomes.

View Article and Find Full Text PDF

Patients with atrial fibrillation, venous thrombosis, and mechanical heart valve (MHV) regularly undergo procedures on a daily basis, for which they require bridging anticoagulation, but this poses significant challenges. Bridging anticoagulation involves temporary interruption of long-term anticoagulation therapy for procedures and continued overlap with short-acting anticoagulants during perioperative period. Heparin-based agents are often used for overlapping in perioperative period to reduce the risk of thromboembolism, but the evidence for benefit particularly in patients with MHV remains limited.

View Article and Find Full Text PDF

Background: Chronic kidney disease (CKD) is associated with a higher prevalence of valvular diseases and increased mortality from cardiovascular causes. Factors that influence the genesis of cardiac valve calcification (CVC) in these patients are not well-defined.

Objective: To determine the risk factors for valvular calcification in patients with CKD.

View Article and Find Full Text PDF

Background: Transcatheter pulmonary valve implantation (TPVI) has emerged as a viable alternative to surgical pulmonary valve replacement for patients with congenital heart disease and right ventricular outflow tract dysfunction. However, its adoption in low-resource settings has been limited.

Case Summary: We report the first successful TPVI procedures in Tanzania.

View Article and Find Full Text PDF